Big Rock Partners Acquisition

YTD

ALL

Why Robinhood?

You can watch BRPA and buy or sell other stocks, ETFs, and their options commission-free!

About BRPA

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

CEO

Jonathan C. Javitt, MD

CEOJonathan C. Javitt, MD

Employees

—

Employees—

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

2017

Founded2017

Employees

—

Employees—

BRPA Key Statistics

Market cap

6.83M

Market cap6.83M

Price-Earnings ratio

-1.60

Price-Earnings ratio-1.60

Dividend yield

—

Dividend yield—

Average volume

257.47K

Average volume257.47K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.01

52 Week high$6.01

52 Week low

$1.10

52 Week low$1.10

People also own

Based on the portfolios of people who own BRPA. This list is generated using Robinhood data, and it’s not a recommendation.

Ocugen, Inc

Churchill Capital

Virgin Galactic Holdings

Bionano Genomics

QuantumScape

FuelCell Energy